TNFRSF9 and cancer: They demonstrated that CD137+ T-cells are present in small percentages in the peripheral blood and, to a larger extent, in ascites and even more inside the tumor, showing a progressive hierarchy with the T-cells in a closer proximity to cancer cells expressing the higher percentages of CD137 and then decreasing gradually toward the periphery.